BMEA Biomea Fusion, Inc.
1.320USD+5.60%Mkt Cap: 95.68M $P/E: —1d ago
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It's lead clinical program's drug candidat…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap95.68M USD
Enterprise Value56.66M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-61.80M USD
Revenue/Share—
Last Price1.320 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees37
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.33
PEG—
EV/EBITDA-1.02
EV/Revenue—
P/S—
P/B7.49
EPS (TTM)-0.28
EPS (Forward)-0.94
52W Range
0.872021% of range2.990
52W High2.990 USD
52W Low0.8720 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-209.11%
ROA-105.51%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-70.37M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-29.05%
Net Debt-33.95M USD
Net Debt/EBITDA0.61
Balance Sheet
Debt/Equity0.05
Current Ratio3.48
Quick Ratio3.32
Book Value/Sh0.17 USD
Cash/Share0.48 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.500 USD
Upside (mean)+392.4%
Target Range4.000 USD – 9.000 USD
4.000+392.4% to mean9.000
# Analysts6
Ownership
Shares Out.72.48M
Float67.67M
Insiders7.15%
Institutions40.02%
Short Interest
Short Ratio5.9d
Short % Float22.24%
Short % Out.18.24%
Shares Short13.22M
Short (prev mo.)9.82M
Technical
SMA 501.499 (-11.9%)
SMA 2001.415 (-6.7%)
Beta-0.30
S&P 52W Chg16.45%
Avg Vol (30d)2.23M
Avg Vol (10d)2.43M
Technical Indicators
RSI (14)41.5
MACD-0.0810
MACD Signal-0.0421
MACD Hist.-0.0389
BB Upper2.020 USD
BB Middle1.530 USD
BB Lower1.041 USD
BB Width64.00%
ATR (14)0.1165 USD
Vol Ratio (20d)0.39x